Skip to content
Subscriber Only

Biotech Pair Halted After IPO Craze Triggers Massive Rallies

  • Shares of Scopus Biopharma soared more than 700% on Thursday
  • Vivos Therapeutics trimmed its gains after trading resumed

The surge in two freshly minted stocks on Thursday triggered trading halts amid a frenzied rush into initial public offerings.

Scopus Biopharma Inc., a cancer-therapy developer, soared as much as 708%, following a 7.6% jump in its Wednesday debut. Meanwhile, medical-technology company Vivos Therapeutics Inc. trimmed its advance to 28% when trading resumed, after almost doubling earlier in the day.